JP2024119830A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024119830A5 JP2024119830A5 JP2024081593A JP2024081593A JP2024119830A5 JP 2024119830 A5 JP2024119830 A5 JP 2024119830A5 JP 2024081593 A JP2024081593 A JP 2024081593A JP 2024081593 A JP2024081593 A JP 2024081593A JP 2024119830 A5 JP2024119830 A5 JP 2024119830A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- vector
- shrna
- nucleotide sequence
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108091027967 Small hairpin RNA Proteins 0.000 claims 11
- 239000004055 small Interfering RNA Substances 0.000 claims 11
- 239000013598 vector Substances 0.000 claims 9
- 239000002773 nucleotide Substances 0.000 claims 8
- 125000003729 nucleotide group Chemical group 0.000 claims 8
- 102000012304 Bestrophin Human genes 0.000 claims 5
- 108050002823 Bestrophin Proteins 0.000 claims 5
- 108050003623 Bestrophin-1 Proteins 0.000 claims 5
- 239000002245 particle Substances 0.000 claims 5
- 208000023068 Autosomal recessive bestrophinopathy Diseases 0.000 claims 3
- 108091026890 Coding region Proteins 0.000 claims 3
- 241000702421 Dependoparvovirus Species 0.000 claims 3
- 108091081021 Sense strand Proteins 0.000 claims 3
- 230000000692 anti-sense effect Effects 0.000 claims 3
- 208000006999 bestrophinopathy Diseases 0.000 claims 3
- 239000013603 viral vector Substances 0.000 claims 3
- 206010025412 Macular dystrophy congenital Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 201000007790 vitelliform macular dystrophy Diseases 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 210000005260 human cell Anatomy 0.000 claims 1
- 239000013612 plasmid Substances 0.000 claims 1
- 239000013608 rAAV vector Substances 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862726184P | 2018-08-31 | 2018-08-31 | |
| US62/726,184 | 2018-08-31 | ||
| US201862749622P | 2018-10-23 | 2018-10-23 | |
| US62/749,622 | 2018-10-23 | ||
| US201862754530P | 2018-11-01 | 2018-11-01 | |
| US62/754,530 | 2018-11-01 | ||
| JP2021511541A JP2021534796A (ja) | 2018-08-31 | 2019-08-30 | ベスト病の処置のためのアデノ随伴ウイルスベクター |
| PCT/US2019/049163 WO2020047476A1 (en) | 2018-08-31 | 2019-08-30 | Adeno-associated viral vectors for the treatment of best disease |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021511541A Division JP2021534796A (ja) | 2018-08-31 | 2019-08-30 | ベスト病の処置のためのアデノ随伴ウイルスベクター |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024119830A JP2024119830A (ja) | 2024-09-03 |
| JP2024119830A5 true JP2024119830A5 (enExample) | 2024-12-23 |
Family
ID=69644668
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021511541A Pending JP2021534796A (ja) | 2018-08-31 | 2019-08-30 | ベスト病の処置のためのアデノ随伴ウイルスベクター |
| JP2024081593A Pending JP2024119830A (ja) | 2018-08-31 | 2024-05-20 | ベスト病の処置のためのアデノ随伴ウイルスベクター |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021511541A Pending JP2021534796A (ja) | 2018-08-31 | 2019-08-30 | ベスト病の処置のためのアデノ随伴ウイルスベクター |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220033826A1 (enExample) |
| EP (1) | EP3843791A4 (enExample) |
| JP (2) | JP2021534796A (enExample) |
| CN (2) | CN120350002A (enExample) |
| AU (1) | AU2019328577A1 (enExample) |
| CA (1) | CA3110563A1 (enExample) |
| IL (2) | IL321380A (enExample) |
| WO (1) | WO2020047476A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020047476A1 (en) * | 2018-08-31 | 2020-03-05 | University Of Florida Research Foundation, Incorporated | Adeno-associated viral vectors for the treatment of best disease |
| EP4041315A4 (en) * | 2019-09-25 | 2023-11-01 | University Of Utah Research Foundation | Methods and compositions for the expression of constitutively active rap1a from a vmd2 promoter |
| US20230139443A1 (en) * | 2020-02-28 | 2023-05-04 | The Trustees Of The University Of Pennsylvania | Treating autosomal dominant bestrophinopathies and methods for evaluating same |
| WO2024064608A2 (en) * | 2022-09-20 | 2024-03-28 | Intergalactic Therapeutics, Inc. | Best1 vectors and uses thereof |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005507398A (ja) * | 2001-10-09 | 2005-03-17 | デヴェロゲン アクチエンゲゼルシャフト フュア エントヴィックルングスビオローギッシェ フォルシュング | エネルギー恒常性の調節に関与するＢｅｓｔｒｏｐｈｉｎおよびＢｅｓｔｒｏｐｈｉｎ相同性タンパク質 |
| DK2284266T3 (da) * | 2002-11-14 | 2014-01-13 | Thermo Fisher Scient Biosciences Inc | sIRNA-MOLEKYLE MOD TP53 |
| WO2005056761A2 (en) * | 2003-12-05 | 2005-06-23 | Massachusetts Institute Of Technology | REAGENTS AND METHODS FOR IDENTIFICATION OF RNAi PATHWAY GENES AND CHEMICAL MODULATORS OF RNAi |
| JP4543188B2 (ja) * | 2004-03-10 | 2010-09-15 | 学校法人日本医科大学 | ヒトチミジル酸合成酵素に対するＲＮＡｉとして作用するＲＮＡ配列 |
| CN101538569B (zh) * | 2008-08-19 | 2011-07-06 | 香港理工大学深圳研究院 | 抑制人dmt1蛋白的rna、重组体及应用 |
| KR101154538B1 (ko) * | 2009-08-24 | 2012-06-13 | 한국과학기술연구원 | 소뇌에서의 ｇａｂａ 방출 조절제 |
| CN102277434B (zh) * | 2011-07-28 | 2015-11-18 | 上海吉凯基因化学技术有限公司 | 人zfx基因的用途及其相关药物 |
| CN102533982B (zh) * | 2011-12-19 | 2016-01-06 | 上海吉凯基因化学技术有限公司 | 人klf8基因在肿瘤治疗中的新用途 |
| CA2907095C (en) * | 2012-03-16 | 2020-11-03 | The Regents Of The University Of California | A novel rnai molecule delivery platform based on single-sirna and shrna nanocapsules |
| DE18200782T1 (de) * | 2012-04-02 | 2021-10-21 | Modernatx, Inc. | Modifizierte polynukleotide zur herstellung von proteinen im zusammenhang mit erkrankungen beim menschen |
| US9546366B2 (en) * | 2013-03-14 | 2017-01-17 | Raadysan Biotech, Inc. | Replication factor C-40 (RFC40/RFC2) as a prognostic marker and target in estrogen positive and negative and triple negative breast cancer |
| US9732345B2 (en) * | 2013-12-09 | 2017-08-15 | Baylor College Of Medicine | Hippo and dystrophin complex signaling in cardiomyocyte renewal |
| GB201322798D0 (en) * | 2013-12-20 | 2014-02-05 | Oxford Biomedica Ltd | Production system |
| US20180346981A1 (en) * | 2014-11-20 | 2018-12-06 | Massachusetts Eye And Ear Infirmary | Panel-based Genetic Diagnostic Testing for Inherited Eye Diseases |
| EA201791518A1 (ru) * | 2014-12-30 | 2017-10-31 | Селл Кьюр Нейросайансес Лтд. | Способы лечения заболеваний сетчатки |
| CN107287238B (zh) * | 2016-04-11 | 2020-10-16 | 厦门继景生物技术有限责任公司 | 一种基因载体及其用于治疗雷柏氏先天性黑矇2型疾病的基因治疗药物 |
| WO2020047476A1 (en) * | 2018-08-31 | 2020-03-05 | University Of Florida Research Foundation, Incorporated | Adeno-associated viral vectors for the treatment of best disease |
-
2019
- 2019-08-30 WO PCT/US2019/049163 patent/WO2020047476A1/en not_active Ceased
- 2019-08-30 AU AU2019328577A patent/AU2019328577A1/en active Pending
- 2019-08-30 IL IL321380A patent/IL321380A/en unknown
- 2019-08-30 US US17/272,203 patent/US20220033826A1/en active Pending
- 2019-08-30 EP EP19854295.3A patent/EP3843791A4/en active Pending
- 2019-08-30 JP JP2021511541A patent/JP2021534796A/ja active Pending
- 2019-08-30 CN CN202510424401.8A patent/CN120350002A/zh active Pending
- 2019-08-30 CA CA3110563A patent/CA3110563A1/en active Pending
- 2019-08-30 CN CN201980067514.XA patent/CN112839682B/zh active Active
-
2021
- 2021-02-24 IL IL281083A patent/IL281083A/en unknown
-
2024
- 2024-05-20 JP JP2024081593A patent/JP2024119830A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024119830A5 (enExample) | ||
| JP6387350B2 (ja) | 希突起神経膠細胞を標的とするアデノ随伴ウイルスベクター | |
| JP2024095717A5 (enExample) | ||
| JP2019519219A5 (enExample) | ||
| JP2025016451A5 (enExample) | ||
| JP2022185052A5 (enExample) | ||
| JP2021502060A5 (enExample) | ||
| TW201629225A (zh) | 第九因子基因療法 | |
| JP2019513779A5 (enExample) | ||
| JPWO2020069461A5 (enExample) | ||
| JP2019524090A5 (enExample) | ||
| JP2019515663A5 (enExample) | ||
| CN113195719A (zh) | 用于增加蛋白质表达和/或治疗单倍剂量不足症的方法及组合物 | |
| JP2020527167A5 (enExample) | ||
| JP2018533976A5 (enExample) | ||
| JP2018509154A5 (enExample) | ||
| IL321380A (en) | Adeno-associated viral vectors for the treatment of best disease | |
| JP2020503014A5 (enExample) | ||
| JPWO2020047476A5 (enExample) | ||
| US12415850B2 (en) | Compositions and methods for regulating production of an antibody like protein and ribonucleic acid | |
| US20030220287A1 (en) | Antisense nucleic acids | |
| JP2019513395A5 (enExample) | ||
| WO2011111072A2 (en) | Adeno-associated virus ezh2 shrna (aav ezh2 shrna)therapy for breast cancer | |
| JPWO2019232517A5 (enExample) | ||
| CN112011571A (zh) | 一种用于治疗脊髓性肌萎缩的基因治疗药物 |